| Landmark Of Bardstown Rehabilitation And Nursing | |
| 120 Life Care Way, Bardstown, Kentucky 40004 | |
| (502) 348-4220 | |
| Name | Landmark Of Bardstown Rehabilitation And Nursing |
|---|---|
| Location | 120 Life Care Way, Bardstown, Kentucky |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 63.4% |
| Medicare ID (CCN) | 185149 |
| Legal Business Name | Landmark Of Bardstown Rehabilitation And Nursing Center |
| Ownership Type | For Profit - Individual |
| NPI Number | 1114470937 |
| Organization Name | BARDSTOWN HEALTHCARE AND REHABILITATION CENTER LLC |
| Doing Business As | BARDSTOWN HEALTHCARE AND REHABILITATION CENTER |
| Address | 120 Life Care Way, Bardstown, KY 40004 |
| Phone Number | 502-348-4220 |
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
| NPI Number | 1356839310 |
| Organization Name | LANDMARK OF BARDSTOWN REHABILITATION AND NURSING CENTER |
| Address | 120 Life Care Way, Bardstown, KY 40004 |
| Phone Number | 502-348-4220 |
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
| NPI Number | 1467662122 |
| Organization Name | LIFE CARE CENTER OF BARDSTOWN |
| Address | 120 Life Care Way, Bardstown, KY 40004 |
| Phone Number | 502-348-4220 |
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
| NPI Number | 1700823549 |
| Organization Name | BARDSTOWN MEDICAL INVESTORS LIMITED |
| Doing Business As | LIFE CARE CENTER OF BARDSTOWN |
| Address | 120 Life Care Way, Bardstown, KY 40004 |
| Phone Number | 502-348-4220 |
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.4 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.21 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.32 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.81 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.69 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.91 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 6.67 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.43 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 8.94 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 36.57 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.55 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.5 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.72 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.17 | 82.93 |
News Archive
End-stage heart failure patients being treated in hospices have multiple symptoms with potential to cause distress, indicate US study findings.
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.
Researchers at the Krembil Neuroscience Centre's Canadian Concussion Centre have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.
Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.
› Verified 6 days ago
Landmark Of Bardstown Rehabilitation And Nursing Location: 120 Life Care Way, Bardstown, Kentucky 40004 Phone: (502) 348-4220 | |
Signature Healthcare At Colonial Rehab & Wellness Location: 708 Bartley Avenue, Bardstown, Kentucky 40004 Phone: (502) 348-9260 | |
Flaget Memorial Hospital Nf Location: 4305 New Shepherdsville Road, Bardstown, Kentucky 40004 Phone: (502) 350-5000 |